Antiarrhythmic drugs |
Type 1A (TdP reported in all) |
Quinidine (TdP reported) |
Procainamide (TdP reported) |
Disopyramide (TdP reported) |
Ajmaline (TdP reported) |
|
Type 1C (increase QT by prolonging QRS interval) |
Encainide |
Flecainide |
|
Type 3 (TdP reported in all) |
Amiodarone |
Sotalol |
d-Sotalol |
Bretylium |
Ibutilide |
Dofetilide |
Amakalant |
Semantilide |
Calcium channel blockers |
Prenylamine (TdP reported, withdrawn) |
Bepridil (TdP reported, withdrawn) |
Terodiline (TdP reported, withdrawn) |
Psychiatric drugs |
Thioridazine (TdP reported) |
Chlorpromazine (TdP reported) |
Haloperidol (TdP reported) |
Droperidol (TdP reported) |
Amitriptyline |
Nortriptyline |
Imipramine (TdP reported) |
Desipramine (TdP reported) |
Clomipramine |
Maprotiline (TdP reported) |
Doxepin (TdP reported) |
Lithium (TdP reported) |
Chloral hydrate |
Sertindole (TdP reported, withdrawn in the UK) |
Pimozide (TdP reported) |
Ziprasidone |
Antihistamines |
Terfenadine (TdP reported, withdrawn in the USA) |
Astemizole (TdP reported) |
Diphenhydramine (TdP reported) |
Hydroxyzine |
Ebastine |
Loratadine |
Mizolastine |
Antimicrobial and antimalarial drugs |
Erythromycin (TdP reported) |
Clarithromycin (TdP reported) |
Ketoconazole |
Pentamidine (TdP reported) |
Quinine |
Chloroquine (TdP reported) |
Halofantrine (TdP reported) |
Amantadine (TdP reported) |
Sparfloxacin |
Grepafloxacin (TdP reported, withdrawn in the UK and USA) |
Pentavalent antimonial meglumine |
Serotonin agonists/antagonists |
Ketanserin (TdP reported) |
Cisapride (TdP reported, withdrawn in the UK and USA) |
Immunosuppressant |
Tacrolimus (TdP reported) |
Antidiuretic hormone |
Vasopressin (TdP reported) |
Other agents |
Adenosine |
Organophosphates |
Probucol (TdP reported) |
Papaverine (TdP reported) |
Cocaine |